Cannabis Stocks Rally to Best Weekly Performance in Two Years

Cannabis equities are experiencing their strongest weekly performance in over two years, with major operators posting double-digit gains as institutional sentiment shifts toward the beleaguered sector. The AdvisorShares Pure US Cannabis ETF (MSOS) has climbed 18% this week, while individual names like Curaleaf Holdings (CURLF) and Green Thumb Industries (GTBIF) have surged 22% and 19% respectively.

The rally stems from renewed optimism around federal cannabis policy reform following recent congressional committee discussions on banking legislation. Financial institutions have begun reassessing their positions on cannabis exposure, with several regional banks quietly exploring partnerships with state-licensed operators. This institutional warming represents a fundamental shift from the risk-averse stance that has dominated the sector since 2022.

Operational improvements across major multi-state operators are finally translating into stock performance. Companies have spent the past 18 months cutting costs, optimizing cultivation facilities, and streamlining operations to achieve profitability despite federal tax burdens. Gross margins have expanded industry-wide, with leading operators now generating positive EBITDA consistently.

Market dynamics are also favoring established players as oversupply conditions ease in key states like California and Colorado. Wholesale prices have stabilized after two years of decline, while retail demand continues growing steadily. The combination of improving unit economics and reduced competition from smaller operators creates a more favorable environment for publicly traded cannabis companies.

This week's momentum could signal a broader sector rotation as investors hunt for undervalued growth opportunities. Cannabis stocks trade at significant discounts to traditional consumer goods companies despite comparable revenue growth rates. If regulatory headwinds continue diminishing and operational metrics keep improving, the sector may finally attract the institutional capital that has remained sidelined since the initial legalization euphoria faded.